fda warning peptides bpc-157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank FDA advisory committee votes to

Patients with Leber's hereditary optic neuropathy should avoid cyanocobalamin (hydroxocobalamin is preferred in the UK)

As of June 2026, the FDA's December 2024 Pharmacy Compounding Advisory Committee evaluation concluded that the criteria weighed against placing AOD-9604 (free base) or AOD-9604 acetate on the 503A Bulks List, and AOD-9604 is currently listed as Nominated but Withdrawn from FDA Category 2

When we use Radiesse we mix in lidocaine, making the treatments exactly the same for our patients

Clinical trials have shown that patients on Semaglutide can lose up to 15% of their body weight over 68 weeks, whereas Phentermine users typically see an average loss of 5-10% of body weight over a shorter period